Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03070028
What this trial is testing

Minimally Invasive Treatment Methods for Pilonidal Disease

Who this might be right for
Pilonidal Sinus
Uşak University 200
Not applicableLooking for participantsNCT07714811
What this trial is testing

Hyaluronic Acid Versus Platelet-Rich Plasma for Chronic Tendinopathy and Enthesopathy

Who this might be right for
TendinopathyEnthesopathyAchilles Tendinopathy+2 more
Ortonika Orthopedic Medical Clinic in Lublin 80
Not applicableUnknownNCT05378971
What this trial is testing

Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma

Who this might be right for
Multiple Myeloma
LanZhou University 15
Large-scale testing (Phase 3)Looking for participantsNCT05020236
What this trial is testing

Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Who this might be right for
Multiple Myeloma
Pfizer 893
Not applicableUnknownNCT06178809
What this trial is testing

Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Singlera Genomics Inc. 475
Not applicableActive Not RecruitingNCT05129904
What this trial is testing

Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)

Who this might be right for
DPMAS Therapy in Liver Disease Patients
Nanfang Hospital, Southern Medical University 1,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05393804
What this trial is testing

Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 24
Large-scale testing (Phase 3)Study completedNCT02211521
What this trial is testing

Comparison of Autologous Platelet-rich Plasma With Hyaluronic Acid for the Treatment of Osteoarthritis of the Knee Joint

Who this might be right for
Osteoarthritis, Knee
Samsung Medical Center 110
Early research (Phase 1)Study completedNCT00070616
What this trial is testing

Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support

Who this might be right for
LeukemiaLymphomaMyeloma
Swedish Orphan Biovitrum 25
Testing effectiveness (Phase 2)UnknownNCT03697655
What this trial is testing

Pre-emptive Daratumumab Therapy of Minimal Residual Disease Reappearance or Biochemical Relapse in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Polish Myeloma Consortium 274
Not applicableUnknownNCT02233933
What this trial is testing

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Who this might be right for
Rectal Bleeding
British Columbia Cancer Agency 20
Early research (Phase 1)Looking for participantsNCT05363111
What this trial is testing

Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
City of Hope Medical Center 15
Not applicableUnknownNCT06244121
What this trial is testing

Effect of Pyridoxine as Add-on Therapy in OCD Patients

Who this might be right for
OCD
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 76
Large-scale testing (Phase 3)Looking for participantsNCT07555938
What this trial is testing

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 380
Early research (Phase 1)Looking for participantsNCT05976555
What this trial is testing

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 30
Testing effectiveness (Phase 2)Ended earlyNCT00872300
What this trial is testing

PHA-739358 for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nerviano Medical Sciences 7
Testing effectiveness (Phase 2)WithdrawnNCT01541098
What this trial is testing

A Clinical Study of Lyophilized Plasma in Patients on Warfarin

Who this might be right for
Anticoagulant Therapy
HemCon Medical Technologies, Inc
Testing effectiveness (Phase 2)Study completedNCT04374565
What this trial is testing

Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia

Who this might be right for
Corona Virus InfectionSARS-CoV 2SARS Pneumonia+1 more
University of Virginia 29
Testing effectiveness (Phase 2)Study completedNCT04468009
What this trial is testing

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Who this might be right for
SARS-Associated CoronavirusCovid19SARS-CoV Infection
Hospital de Infecciosas Francisco Javier Muniz 134
Early research (Phase 1)Study completedNCT01497093
What this trial is testing

Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 34
Next Page